Ties That Bind
Open Access
- 28 November 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 165 (21) , 2493-2496
- https://doi.org/10.1001/archinte.165.21.2493
Abstract
Interactions between medical specialists and pharmaceutical manufacturers are important for the development and evaluation of new medicines. However, interaction with industry has the capacity to create conflicts of interest. While these risks are well recognized, studies have shown that physicians underestimate the potential for different interactions to cause problems. For instance, many do not consider that acceptance of small gifts creates an ethical dilemma.1-3 Interaction with industry in one area may lead to the development of other ties. The development of multiple ties may blur professional boundaries and responsibilities. Research collaboration, an important and growing area of engagement between industry and clinical researchers, may lead to other significant relationships, such as advisory panel membership, payment for consultation to the industry, and substantial recompense to attend international conferences.4-6 These ties may create a sense of collegiality, and the resulting obligation and need to reciprocate may not be consciously felt.2,7-9 The term “entanglement” has been used to describe this process, but there has been little direct research into the development of multiple ties.10,11This publication has 12 references indexed in Scilit:
- Medical specialists and pharmaceutical industry‐sponsored research: a survey of the Australian experienceThe Medical Journal of Australia, 2005
- Implementation Of Financial Disclosure Policies To Manage Conflicts Of InterestHealth Affairs, 2004
- Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire surveyPharmacoepidemiology and Drug Safety, 2003
- The Invisible Influence of Industry InducementsAmerican Journal of Bioethics, 2003
- A Social Science Perspective on Gifts to Physicians From IndustryJAMA, 2003
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: EntanglementBMJ, 2003
- Nonfinancial Conflicts of Interest in ResearchNew England Journal of Medicine, 2002
- Assessing faculty financial relationships with industry: a case studyAmerican Journal of Ophthalmology, 2001
- Uneasy Alliance — Clinical Investigators and the Pharmaceutical IndustryNew England Journal of Medicine, 2000
- Is Academic Medicine for Sale?New England Journal of Medicine, 2000